✦ LIBER ✦

Chest irradiation as an attempt to improve the response after induction chemotherapy in small cell lung carcinoma

Book ID: 122341148
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 197 KB
Volume: 2
Category: Article
ISSN: 0169-5002
DOI: 10.1016/S0169-5002(86)80801-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Retreatment with the induction regimen i

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Retreatment with the induction regimen i

Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy

✍ Postmus, Pieter E.; Berendsen, Henk H.; van Zandwijk, Nico; Splinter, Ted A.W.; 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 304 KB

Prophylactic Cranial Irradiation is More

Prophylactic Cranial Irradiation is More Important to Improve the Overall Survival among Patients with Limited Small–cell Lung Cancer Who Received One-Cycle Induction Chemotherapy and Had Complete Response to Therapy

✍ Wei, X.; Allen, P.K.; Liao, Z.; Chang, J.Y.; Guerrero, T.M.; Cox, J.D.; Komaki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Normal serum neuron specific enolase (NS

Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy : An early predictor of complete response and survival in patients with small cell lung carcinoma

✍ Karim Fizazi; Isabelle Cojean; Jean-Pierre Pignon; Olivier Rixe; Michel Gatineau 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

BACKGROUND. Serum neuron specific enolase (NSE) is the most sensitive tumor

Marimastat may not improve survival over

Marimastat may not improve survival over placebo following induction therapy for small-cell lung cancer: Abstracted from: Shepherd F, Giaccone G, Seymour L et al. Prospective, randomized, double-blind, placebo-controlled trial of marimastat after response to first-line chemotherapy in patients with small-cell lung cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group and the European Organization for Research and Treatment of Cancer. J Clin Oncol 2002; 20(22): 4434–39.

✍ B Coudert 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 71 KB